Clinical Trial Update: Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and pharmacokinetics data for AT-007 were reported in healthy subjects and adults with Classic Galactosemia. The results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Galactosemia

Drugs mentioned

• AT 007

Snippet

Sponsor: Applied Therapeutics, Inc. | Conditions: Classic Galactosemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-30